Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease

• Status: Completed
• Trial end date: 2005-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Aging (NIA)
• Collaborator: Burke Medical Research Institute

Criteria

Inclusion criteria include:

• A documented diagnosis of Alzheimer's disease;

• MMSE score between 10 and 26 inclusive;

• A reliable caregiver to ensure compliance.

Exclusion criteria include:

• diabetes, unstable medical illness, myocardial infarction or cancer diagnosed within the previous 12 months, or treatment with systemic steroids.

• Patients being treated for depression or other psychiatric symptomatology are eligible, if their symptoms are under control on a stable dose of medication